BIOS Fund II, LP's Form 4 filing
IN8BIO, Inc. (INAB) · filed Sep 29, 2022
- Accession no.
- 0001104659-22-103860
- Filed
- Sep 29, 2022, 6:14 AM ET
- Trade date
- Sep 28, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $50.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| BIOS Fund II, LPCIK 0001714576 | Director, 10% Owner |
| BIOS Fund II QP, LPCIK 0001716869 | Director, 10% Owner |
| BIOS Fund II NT, LPCIK 0001728851 | Director, 10% Owner |
| BIOS Incysus Co-Invest I, LPCIK 0001740029 | Director, 10% Owner |
| Fletcher Aaron G.L.CIK 0001789490 | Director, 10% Owner |
| BIOS Fund III NT, LPCIK 0001791910 | Director, 10% Owner |
| BIOS Fund III QP, LPCIK 0001791916 | Director, 10% Owner |
| BIOS Fund III, LPCIK 0001791917 | Director, 10% Owner |
| BIOS Advisors GP, LLCCIK 0001813844 | Director, 10% Owner |
| BIOS Capital Management, LPCIK 0001813845 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2022 | Common Stock | PPurchaseAcquired | +3,070 | $2.02 | +$6,205.7 | 592,766 | Indirect | Duplicate filing |
| Sep 28, 2022 | Common Stock | PPurchaseAcquired | +19,017 | $2.02 | +$38,440.96 | 3,670,545 | Indirect | Duplicate filing |
| Sep 28, 2022 | Common Stock | PPurchaseAcquired | +2,913 | $2.02 | +$5,888.34 | 561,989 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.